Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $144.00, but opened at $129.41. Pro Medicus shares last traded at $129.41, with a volume of 1,000 shares traded.
Analyst Ratings Changes
Separately, Jefferies Financial Group cut Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $155.00.
Read Our Latest Research Report on Pro Medicus
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
See Also
- Five stocks we like better than Pro Medicus
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
- MarketBeat Week in Review – 08/24 – 08/28
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
